-
Revised Prostate Cancer Screening Guidelines Proposed
The U.S. Preventive Services Task Force suggests an individualized approach to prostate cancer screening.
-
Immunotherapy Combinations
Researchers are combining immunotherapies with each other and with other treatments in hopes that a larger proportion of patients will have long-term benefits.
by Kate Yandell
-
From the Editor-in-Chief
Palliative Care: Putting a Cloak on CancerPatients should have access to this vital and emerging medical specialty.
by William G. Nelson, MD, PhD
-
Forward Look
Inside InflammationQ&A with molecular biologist Michael Karin on inflammation and cancer.
by Robin Meadows
-
Forward Look
Making Treatment DecisionsPersonal goals come into play for patients with advanced cancer.
by Kendall K. Morgan
-
Forward Look
Advances in Treating Non–Small Cell Lung CancerExpanded approvals in 2016 increase options.
by Jennifer L.W. Fink
-
Forward Look
Cancer Cells Can Change as They Grow and SpreadStudies suggest metastases may respond to different drugs than the primary tumor.
by Chris Palmer
-
A Prescription for Prevention?
Scientists are working to understand the molecular processes that transform normal cells into cancer cells in the hope they can prevent the disease before it starts.
by Marci A. Landsmann
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles